Abstract

AbstractAll optical isomers of an optically active medicinal substance require experimental and clinical testing. In this process, as a rule, in silico methods are used in the first stage of screening for pharmacologically active substances. These methods predict the activity of chiral structures.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call